Ivivcs and the potential impact of variability in regional airway deposition patterns on the bioequivalence of pulmonary products
- In: MINI-SYMPOSIUM: CHALLENGES IN BIOEQUIVALENCE FOR INHALED PRODUCTS on Monday, 14 April 2014, 09:00-10:00
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: CLARK, Andy (Novartis, TRD, San carlos, United States of America)
Over the years in-vitro testing of pharmaceutical aerosols has improved dramatically. In the seventies technologies developed by the industrial hygiene industry were adapted for pharmaceuticals. This led to the use of instruments like the Andersen impactor and the MSLI, and the design of single stage impactors such as the Twin impinger and Metal.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.